NASDAQ$FLGT

Fulgent Genetics Inc. · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

Fulgent Genetics reported record fourth quarter financial results driven by COVID-19 testing and growth in core business.

Fulgent Genetics reported a record fourth quarter with revenue of $295.0 million, an increase of 3,400% year-over-year. GAAP income was $166.3 million, or $6.16 per share, and non-GAAP income was $167.5 million, or $6.20 per share.

  • Record Revenue of $295.0 million, growing more than 3,400% year-over-year
  • Record Billable tests delivered approximately 3.2 million, approximately 230 times the volume of fourth quarter of 2019
  • Record GAAP income of $166.3 million, or $6.16 per share
  • Non-COVID Revenue grew 43% year-over-year

Headline financials

Total Revenue

$295M

Previous: $8.39M+3417.1%
EPS (adj)

$6.20

Previous: $0.04+15400.0%
Net Income

$166M

Previous: -$296K+56284.8%
Operating Income

$226M

Previous: -$409K+55334.5%
Gross Profit

$243M

No prior period
Cash & Equivalents

$87.4M

Previous: $12M+630.7%
Total Assets

$700M

Previous: $88.8M+689.2%

Revenue & EPS history

Fulgent · Revenue · Quarterly

$295M

Q4 2020+3,417.1%vs Q4 2019
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Fulgent · $66M total across 1 segment · Q3 2023

  • Core Revenue
    $66M+17.9%

Forward guidance

The company expects to generate revenue of at least $325.0 million for the first quarter of 2021. For the full year 2021, the company expects revenue of approximately $800.0 million, with approximately $70.0 million from NGS testing and GAAP income of approximately $380.0 million, or more than $12.00 per share, and non-GAAP income of approximately $12.50 per share.

Tailwinds

  • Expects overall revenue of approximately $800.0 million in 2021, representing growth of 90% year-over-year
  • Anticipates $70.0 million of NGS testing revenues in 2021, representing 92% growth year-over-year
  • Expects GAAP income of approximately $12.00 per share in 2021
  • Expects non-GAAP income of approximately $12.50 per share in 2021
  • Expects to drive strong gross and operating margins by leveraging the company’s proprietary technology platform

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-2.5%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-1.3%

Avg return

30 days after

37%

15 / 41 earnings

Positive

+38.3%

Q3 2019

Best reaction

-38.1%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-7.0%-1.8%+19.2%
Q4 2025-38.1%-43.5%-37.0%
Q3 2025+18.3%+30.3%+24.6%
Q1 2025+18.7%+8.1%+20.1%
Q4 2024-1.5%+6.1%+8.7%
Q3 2024-9.0%-16.3%-8.8%
Q2 2024+0.4%-0.3%-4.3%
Q1 2024+1.2%+0.1%-2.8%
Q4 2023-11.5%-6.8%-14.8%
Q3 2023+14.0%+11.1%+15.5%
Q2 2023-15.4%-18.1%-18.6%
Q1 2023+16.1%+23.4%+41.4%
Q4 2022-2.5%+3.3%-9.1%
Q3 2022-8.6%+3.3%-2.4%
Q2 2022-4.9%-20.4%-33.9%
Q1 2022+4.4%-4.1%-1.6%
Q4 2021-1.3%+0.1%-2.1%
Q3 2021-1.1%+10.5%+4.3%
Q2 2021-8.0%-10.9%-15.2%
Q1 2021+3.9%-2.5%+2.6%
Q4 2020-0.5%+18.1%+8.3%
Q3 2020-17.0%+6.9%+20.0%
Q2 2020+27.2%+26.1%+13.2%
Q1 2020-21.0%+3.9%+10.3%
Q4 2019-32.3%-42.6%-29.1%
Q3 2019+38.3%+68.1%+26.0%
Q2 2019+31.9%+45.4%+46.7%
Q1 2019-15.8%-16.5%-11.3%
Q4 2018+9.6%+7.6%+29.3%
Q3 2018+6.9%+12.3%+2.8%
Q2 2018-0.8%-4.9%-17.9%
Q1 2018-0.3%-2.3%-4.9%
Q4 2017-9.1%-20.9%-15.6%
Q3 2017+0.4%-4.0%+0.9%
Q2 2017-15.6%-9.9%-16.4%
Q1 2016-31.1%-30.0%-53.4%
Q1 2017-33.1%-29.4%-53.9%
Q2 2016-3.8%-9.0%-7.5%
Q4 2016+1.1%-4.2%-2.9%
Q4 2015-1.6%-1.7%+8.2%
Q3 2016-3.1%-4.1%+9.5%
Q3 2015
Q2 2015
Q1 2015

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro